THROMBOCYTOPENIA
Clinical trials for THROMBOCYTOPENIA explained in plain language.
Never miss a new study
Get alerted when new THROMBOCYTOPENIA trials appear
Sign up with your email to follow new studies for THROMBOCYTOPENIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New shot aims to stop Chemo's dangerous side effect
Disease control CompletedThis early study tested a new drug called PN20 in 24 adults with lymphoma or solid tumors who had low platelets from chemotherapy. The goal was to see if a single shot before chemo is safe and can help prevent dangerously low platelet counts. Results will guide future research on…
Matched conditions: THROMBOCYTOPENIA
Phase: PHASE1 • Sponsor: Chongqing Peg-Bio Biopharm Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 07:34 UTC
-
New hope for lymphoma patients: drug may prevent chemo side effect
Prevention CompletedThis study tested whether the drug romiplostim can prevent severe low platelet counts caused by chemotherapy in lymphoma patients. Eleven adults with lymphoma receiving chemo known to lower platelets took part. The goal was to see if romiplostim could reduce the need for chemo de…
Matched conditions: THROMBOCYTOPENIA
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Prevention
Last updated May 26, 2026 07:26 UTC
-
Lowering platelet transfusion trigger found safe for central line placement
Knowledge-focused CompletedThis study involved 927 patients with blood disorders who needed a central line (a special IV). Researchers wanted to see if using a lower platelet count threshold (10,000 instead of 50,000) before the procedure would still be safe. They focused on moderate to severe bleeding eve…
Matched conditions: THROMBOCYTOPENIA
Sponsor: Thomas Kander • Aim: Knowledge-focused
Last updated May 26, 2026 07:42 UTC
-
Researchers collect blood from patients with dangerously low platelets
Knowledge-focused CompletedThis study collected one blood sample from 40 adults with very low platelets caused by blood cancer or its treatment. The goal was to gather samples for future research, not to test a new treatment. Participants had platelet counts of 30,000 or lower and were not on blood thinner…
Matched conditions: THROMBOCYTOPENIA
Sponsor: Case Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated May 26, 2026 07:24 UTC
-
Generic Blood-Clotting drug put to the test in healthy volunteers
Knowledge-focused CompletedThis study checked if a generic version of eltrombopag (a drug that helps increase blood platelets) works the same as the brand-name drug in healthy adults after eating. Thirty-six healthy Chinese volunteers took both versions at different times to compare how their bodies absorb…
Matched conditions: THROMBOCYTOPENIA
Phase: NA • Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. • Aim: Knowledge-focused
Last updated May 22, 2026 13:53 UTC
-
New test may improve platelet transfusions for patients with low blood counts
Knowledge-focused CompletedThis study looked at 68 people who need frequent platelet transfusions because of low platelet counts. Researchers tested whether a new method (C1q binding) could better predict if a transfusion would help compared to the standard test. They used stored blood samples to compare t…
Matched conditions: THROMBOCYTOPENIA
Sponsor: National Institutes of Health Clinical Center (CC) • Aim: Knowledge-focused
Last updated May 15, 2026 11:54 UTC